Positron Emission Tomography (DBCOND0024063)

Identifiers

Synonyms
Positron-Emission Tomography(PET) / Positron Emission Tomography (PET) / PET / Positron-Emission Tomography / Positron emission tomography / Pets / Petting / Positron emission tomography (procedure) / PET scan / Positron emission tomogram / Positron emission tomographic imaging - action (qualifier value) / Petting (finding)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Ammonia N-13
A radioactive diagnostic agent used in PET (positron emission tomography) scans.
Choline C-11
An imaging agent used in positron emission tomography imaging for suspected recurrent prostate cancer and non-informative bone scintigraphy, computerized tomography, or magnetic resonance imaging.
No drug targets
Copper oxodotreotide Cu-64
A Cu labeled somatostatin analog used in positron emission tomography to detect certain types of neuroendocrine tumors.
Dotatate gallium Ga-68
Dotatate gallium 68 is one of the most prominent radiopharmaceuticals used in imaging with positron emission tomography. It binds to the somatostatin-2 receptor which is usually overexpressed in many neuroendocrine...
Edotreotide gallium Ga-68
A radioactive diagnostic agent used in PET scans for somatostatin receptor positive neuroendocrine tumors in adult and pediatric patients.
Florbetaben F-18
A radiopharmaceutical diagnostic agent used during Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients to diagnose the causes of cognitive impairment.
Florbetapir F-18
A radiopharmaceutical diagnostic agent used during Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients to diagnose the causes of cognitive impairment.
Flortaucipir F-18
A small lipophilic tracer containing [18F]fluoride capable of crossing the blood-brain barrier and binding to aggregated tau protein; used in PET imaging for the diagnosis of Alzheimer's disease.
Flotufolastat F-18
A radiopharmaceutical diagnostic agent used in PET imaging to visualize PSMA-positive lesions in men with prostate cancer with suspected metastasis or recurrence.
Fluciclovine (18F)
A radiolabelled L-leucine derivative used to image tumors, especially in the prostate.
Fludeoxyglucose
A radiopharmaceutical indicated for PET scans.
No drug targets
Fludeoxyglucose (18F)
A radiopharmaceutical agent used for positron emission tomography (PET) imaging in oncology, cardiology, and neurology.
Fluoride ion F-18
A diagnostic radiopharmaceutical agent used as a bone imaging agent to delineate areas of altered osteogenesis.
No drug targets
Fluorocholine F-18
A radiopharmaceutical indicated in PET scans of the prostate.
No drug targets
Fluorodopa (18F)
Fluorodopa F 18 is indicated for use with positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes...
Fluoroestradiol F-18
A radiolabeled analog of estradiol used as a contrast agent in the PET imaging of estrogen receptor-positive breast cancer lesions.
Flutemetamol (18F)
A radiopharmaceutical diagnostic agent used during Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients to diagnose the causes of cognitive impairment.
Gallium Ga-68 gozetotide
A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography.
Piflufolastat F 18
A radiopharmaceutical diagnostic agent used with PET to image PSMA-positive lesions for the diagnosis of metastatic or recurrent prostate cancer.
Rubidium Rb-82
A radiopharmaceutical diagnostic agent used for Positron Emission Tomography (PET) imaging of the myocardium to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05989997
Phase I Clinical Trial of 68Ga-NOTA-SNA002No drug interventionsdiagnostic1recruiting
NCT05490264
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid TumorsNo drug interventionsdiagnostic0recruiting
NCT06188468
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid TumorsNo drug interventionsdiagnosticNot Availablecompleted
NCT06324890
PET-CT Imaging Features of Meibomian GlandsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00385164
The Utility of FDG-PET for Radiation Treatment in NSCLCNo drug interventionsNot AvailableNot Availableunknown_status
NCT06203587
Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT05596851
Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy.No drug interventionsNot AvailableNot Availablerecruiting
NCT05873777
68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDGNo drug interventionsdiagnosticNot Availablerecruiting
NCT05610098
Gene Expression Profiles in Spinal Tuberculosis.No drug interventionsNot AvailableNot Availablerecruiting
NCT05392205
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT04533828
68Ga-FAPI PET/CT in Liver Fibrosis PatientsNo drug interventionsdiagnostic0unknown_status
NCT03324893
FCH PET/MRI Parathyroid LocalizationNo drug interventionsdiagnosticNot Availablecompleted
NCT06116188
Brain Insulin Resistance in Mild Cognitive ImpairmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT06148207
[18F]BF3-BPA Injection for PET Imaging Study of Gliomas in the BrainNo drug interventionsdiagnosticNot Availablerecruiting
NCT03636607
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular CarcinomaNo drug interventionsdiagnosticNot Availablerecruiting
NCT03830242
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.No drug interventionsdiagnosticNot Availablerecruiting
NCT01031199
Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy VolunteersNo drug interventionsdiagnostic1completed
NCT03679936
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04831541
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancerdiagnostic0recruiting
NCT06465017
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT04367948
Positron Nuclide Labeled NOTA-FAPI PET Study in LymphomaNo drug interventionsdiagnosticNot Availableunknown_status
NCT04001257
18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading GliomaNo drug interventionsNot AvailableNot Availablecompleted
NCT05506566
68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studiesdiagnostic1 / 2recruiting
NCT04499365
68Ga-FAPI PET/CT in Patients With Various Types of CancerNo drug interventionsdiagnostic0unknown_status
NCT04416165
Comparison of FDG and FAPI in Patients With Various Types of CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT06203574
Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid TumorsNo drug interventionsdiagnosticNot Availablerecruiting
NCT03741231
18FDG-PET in Patients With Melanoma or NSCLC Treated With ImmunotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT06017973
The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status EpilepticusNo drug interventionsdiagnosticNot Availablerecruiting
NCT01721473
Brain Nicotine Receptor Density in Veteran SmokersNo drug interventionsNot AvailableNot Availablecompleted
NCT06084767
68Ga-TCR-FAPI PET/CT in Patients With Various Types of CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT06387381
68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive DiseaseNo drug interventionsdiagnostic0recruiting
NCT01035164
Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy VolunteersNo drug interventionsdiagnostic1completed
NCT06027021
Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PETNo drug interventionsNot AvailableNot Availablecompleted
NCT04660279
Dynamic FDG PET/CT: Optimization and Validation of Data AcquisitionNo drug interventionsdiagnosticNot Availablecompleted
NCT06148233
CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain ImagingNo drug interventionsdiagnosticNot Availablerecruiting
NCT05262647
18F-FAPI PET in the Diagnosis of Liver FibrosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05140083
68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseasesdiagnostic1recruiting
NCT05004961
The Performance of Multi-tracer Multimodality PET in LymphomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT06419361
[68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer PatientsNo drug interventionsdiagnostic0not_yet_recruiting
NCT01956409
Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosisdiagnostic4unknown_status
NCT05856409
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer RecurrenceNo drug interventionsNot AvailableNot Availablerecruiting
NCT06453915
NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Diseaseother0not_yet_recruiting
NCT05516732
Serotonin Release in Premotor and Motor PDNo drug interventionsNot AvailableNot Availablerecruiting
NCT04555642
Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRINo drug interventionsNot AvailableNot Availableunknown_status
NCT06203613
Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT05339113
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast CarcinomaNo drug interventionsdiagnosticNot Availableunknown_status
NCT05970913
PET-CT Predicting Segement Specific Lymph Nodes MetastasisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04478318
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and MelanomaNo drug interventionsbasic_scienceNot Availableenrolling_by_invitation
NCT02983318
Molecular Imaging of Brain Inflammation in Depressive DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT05516719
Longitudinal Investigation of I2BS in PDNo drug interventionsNot AvailableNot Availablerecruiting
NCT05543317
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDGNo drug interventionsdiagnosticNot Availablecompleted
NCT04831034
68Ga-FAPI PET/CT in Patients With Various Fibrotic DiseaseNo drug interventionsdiagnostic0recruiting
NCT04982458
Visualized Monitoring of Fibrosis Formation in Heart Failure With 68GA-FAPI PETNo drug interventionsNot AvailableNot Availableunknown_status
NCT03107663
⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphomadiagnostic1completed
NCT04605939
Clinical Application of Fibroblast Activation Protein PET/MRI in Liver FibrosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT04514822
Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCCNo drug interventionsdiagnosticNot Availableunknown_status
NCT03402425
The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and AdolescentsNo drug interventionsdiagnosticNot Availableunknown_status
NCT06558357
Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia RheumaticaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02599974
PET-CT in the Initial Staging of Breast Cancer and in the Early Assessment of Response to Neoadjuvant ChemotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06148220
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple TumorsNo drug interventionsdiagnosticNot Availablerecruiting
NCT03563482
Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.No drug interventionsdiagnosticNot Availableunknown_status
NCT02988531
Validation of PET-MRI for Cardiovascular DiseaseNo drug interventionsdiagnosticNot Availablecompleted
NCT03180060
Meta-Analysis of Stress Myocardial Perfusion ImagingNo drug interventionsNot AvailableNot Availablecompleted
NCT06270394
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors ApplicationNo drug interventionsdiagnosticNot Availablesuspended
NCT04291144
Visualising Cerebral and Peripheral Cholinergic Nerves in Patients With Dementia Lewy Bodies.No drug interventionsNot AvailableNot Availablecompleted
NCT05757804
Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04750772
Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT05188872
Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAENo drug interventionsdiagnosticNot Availablerecruiting
NCT04515368
A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine ReactogenicityNo drug interventionsbasic_scienceNot Availablecompleted
NCT04525612
68Ga-BNU-PSMA PET/CT in Patients With Various Types of CancerNo drug interventionsdiagnostic0unknown_status
NCT04983095
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate CancerNo drug interventionstreatment3recruiting
NCT02971995
Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT05411250
Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in LymphomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT03802123
⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumorsdiagnostic2completed
NCT06372444
Mechanisms of Acute Kidney Injury in Severe InfectionsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00228514
Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Studytreatment3completed
NCT05636748
The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic StrokeNo drug interventionsNot AvailableNot Availablerecruiting
NCT03943966
In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET RadiotracerNo drug interventionsbasic_scienceNot Availablecompleted
NCT03909828
Precision Medical Diagnosis for Parkinson's Disease - The Quantitative Analysis System for PET/MRI Images in PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05394909
Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA PatientsNot AvailableNot Availableunknown_status
NCT00598286
PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2No drug interventionsdiagnostic1completed